A patient may be able to participate in the trial if they meet eligibility criteria including:

- Confirmed metastatic cancer, for which approved therapies are no longer effective
- Adequate performance status
- Adequate baseline organ function, as measured by laboratory values
- No ongoing therapy, uncontrolled illnesses or infections

The study doctor will review the complete list of the study’s criteria with you to determine your eligibility.

Who may participate